HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic lithium chloride administration to rats decreases brain protein level of epsilon (epsilon) subunit of eukaryotic initiation factor-2B.

Abstract
The eukaryotic initiation factor-2B (eIF-2B) can regulate translation and protein synthesis. We used Western blot analysis to quantify the protein level of the catalytic epsilon (epsilon) subunit of eIF-2B in brains of rats fed lithium chloride (LiCl) for 6 weeks so as to produce a brain lithium concentration that is therapeutically effective in bipolar disorder. The ratio of eIF-2B (epsilon) to actin protein was significantly reduced (P<0.01) in LiCl-fed rats, 0.86+/-0.06 (SE) compared to 1.2+/-0.07 in control rats. These results suggest that a therapeutic level of lithium may downregulate the synthesis of proteins whose translation depends on eIF-2B.
AuthorsFrancesca Bosetti, Ruth Seemann, Stanley I Rapoport
JournalNeuroscience letters (Neurosci Lett) Vol. 327 Issue 1 Pg. 71-3 (Jul 12 2002) ISSN: 0304-3940 [Print] Ireland
PMID12098503 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antimanic Agents
  • Eukaryotic Initiation Factor-2B
  • Lithium Chloride
Topics
  • Animals
  • Antimanic Agents (pharmacology)
  • Bipolar Disorder (drug therapy, metabolism)
  • Brain (drug effects, metabolism)
  • Brain Chemistry (drug effects)
  • Eukaryotic Initiation Factor-2B (metabolism)
  • Lithium Chloride (pharmacology)
  • Male
  • Protein Biosynthesis (drug effects)
  • Rats
  • Rats, Inbred F344

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: